Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Imiquimod × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5 Gastrointestinal 1

Conditions

Colorectal Neoplasms 2 Stomach Neoplasms 1 Squamous Intraepithelial Lesions 1 Papillomavirus Infections 1 HIV Infections 1 Breast Neoplasms 1 Anus Neoplasms 1 Acquired Immunodeficiency Syndrome 1

Interventions

pembrolizumab 33 Capecitabine 25 Paclitaxel 20 Trastuzumab 19 Cyclophosphamide 19 Surveys and Questionnaires 18 Gemcitabine 16 Docetaxel 16 Carboplatin 14 Nivolumab 13 Methods 12 Interviews as Topic 12 Bevacizumab 12 Magnetic Resonance Spectroscopy 11 Irinotecan 11 fludarabine 10 durvalumab 10 Early Intervention, Educational 10 olaparib 9 Standard of Care 9 Specimen Handling 9 Fluorouracil 9 Blood Specimen Collection 9 Albumin-Bound Paclitaxel 9 130-nm albumin-bound paclitaxel 9 palbociclib 8 atezolizumab 8 Taxes 8 Psychiatric Rehabilitation 8 Fulvestrant 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02276300 2019-11-20

HER2

Technical University of Munich

Phase 1 Completed

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡